Logo

WLDS

Wearable Devices Ltd.

WLDS

Wearable Devices Ltd. NASDAQ
$1.93 4.32% (+0.08)

Market Cap $1.74 M
52w High $11.40
52w Low $1.00
Dividend Yield 0%
P/E -0.19
Volume 110.26K
Outstanding Shares 899.79K

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $294K $3.605M $-3.715M -1.264K% $-2.65 $-3.71M
Q4-2024 $128K $3.552M $-3.669M -2.866K% $-9.25 $-3.546M
Q2-2024 $394K $4.3M $-4.21M -1.069K% $-16.52 $-4.167M
Q4-2023 $70K $4.143M $-3.918M -5.597K% $-18.15 $-4.087M
Q2-2023 $12K $4.04M $-3.896M -32.467K% $-0.26 $-4.031M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $3.456M $4.787M $974K $3.813M
Q4-2024 $3.951M $5.976M $2.116M $3.86M
Q2-2024 $3.16M $5.372M $3.677M $1.695M
Q4-2023 $4.855M $7.592M $2.066M $5.526M
Q2-2023 $7.957M $9.369M $1.728M $7.641M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-3.715M $-2.967M $-529K $2.471M $-1.025M $-2.974M
Q4-2024 $-3.669M $-3.752M $-770K $4.508M $-14K $-3.759M
Q2-2024 $-4.21M $-3.861M $3.967M $2.187M $2.293M $-3.897M
Q4-2023 $-3.918M $-4.715M $-2.1M $1.671M $-5.144M $-4.816M
Q2-2023 $-3.896M $-3.719M $-2.148M $1.448M $-4.419M $-3.812M

Five-Year Company Overview

Income Statement

Income Statement Wearable Devices is still in a very early, pre‑revenue stage. Over the past several years it has essentially reported no sales and only small but steady operating losses. In simple terms, the company is spending on development and operations without yet bringing in meaningful product revenue. Earnings per share look very negative, but this is largely a function of the company’s small scale and share structure rather than a sudden collapse in performance. Overall, the income statement reflects a classic early‑stage, R&D‑heavy tech company: costs now, with the hope of commercial returns later, but no clear line yet to profitable operations.


Balance Sheet

Balance Sheet The balance sheet is very light. The company has only a modest asset base and minimal cash, and its equity cushion appears thin. On the positive side, there is effectively no financial debt, which reduces interest burden and refinancing risk. However, the small size of its resources means the business likely has limited room to absorb setbacks without raising new capital. Financially, this looks like a lean, high‑risk balance sheet typical of a young technology company still proving out its market.


Cash Flow

Cash Flow Cash flows tell the same story as the income statement: money is flowing out for operations and development, with no offsetting inflows from sales. Operating cash flow has been consistently negative, and free cash flow is negative as well, even though capital spending is very low. This suggests the main cash drain is staff, R&D, and ongoing operating costs rather than heavy investment in equipment. The business appears dependent on external funding to sustain its activities until commercial traction improves.


Competitive Edge

Competitive Edge Competitively, Wearable Devices is trying to carve out a niche at the intersection of neural interfaces, wearables, and AR/VR. Its technology aims to let users control digital devices using subtle finger movements, which is more advanced than simple motion or gesture tracking. The company has built a growing patent portfolio around its surface nerve conductance technology, which can read neural signals from the wrist and even estimate physical forces like weight or torque. This intellectual property, combined with early recognition at trade shows and relationships with larger tech firms, could provide a differentiation edge. Still, it operates in a fast‑moving field with many better‑funded players, so turning early‑mover and patent strength into durable market share remains uncertain.


Innovation and R&D

Innovation and R&D Innovation is the core of the story. The Mudra platform, including the Apple‑focused Mudra Band, the more universal Mudra Link, and a development kit for partners, is built on non‑invasive neural signal decoding enhanced by AI. The company is also exploring extensions into health monitoring, cognitive state analytics, and even defense applications, where touchless control could be valuable. The roadmap includes ambitions like continuous neuromuscular monitoring and a longer‑term data platform built on bio‑signals. All of this underscores a strong R&D focus and big potential upside if the technology proves robust and finds real‑world use cases. The flip side is heightened execution risk: the company must validate the tech at scale, navigate regulatory and privacy questions in health and data, and convince partners and end users to adopt a novel interaction method.


Summary

Overall, Wearable Devices is a classic early‑stage, high‑innovation, high‑uncertainty technology story. Financially, it is pre‑revenue with ongoing losses, a very lean balance sheet, and negative cash flows, which together imply dependence on external funding and a meaningful risk profile. Strategically, it is aiming at large, fast‑growing markets—AR/VR, advanced wearables, human‑computer interfaces, and potentially health and defense—where its patented neural interface technology could be meaningfully differentiated if it scales. The key things to watch are: clear evidence of recurring commercial revenue, the depth and durability of partnerships with larger hardware players, user acceptance of its input method, and its ability to maintain sufficient funding while it executes its ambitious R&D and product roadmap.